Report on shares re-lodged for transfer cum Demat of Physical shares.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pharmaids Pharmaceuticals has submitted a status report on the re-lodgement of physical share transfer requests to BSE, as required under SEBI's July 2025 special window circular. The company's Registrar & Transfer Agent, Venture Capital and Corporate Investments, provided monthly reports covering status as of August 8, September 5, and October 4, 2025. All three reports show zero requests received, processed, approved, or rejected during the reported periods. This indicates no shareholders have approached the company to re-lodge old physical share transfer requests under this SEBI facility. The disclosure is purely procedural compliance and reflects no business activity or capital changes.
No impact on shareholders or stock price. This is a routine regulatory compliance filing confirming that no shareholders have used the SEBI special window to re-lodge physical share transfer requests with the company.